Page last updated: 2024-08-26

artenimol and Metastase

artenimol has been researched along with Metastase in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Feng, BM; Han, XL; Li, YT; Sun, YC; Tang, L; Yuan, LX1
Gong, W; Hu, Y; Jiang, L; Li, H; Liang, H; Liu, Y; Ma, Q; Wang, X; Wang, Z; Xiang, S; Xu, Z; Ye, Y; Zhang, F; Zhang, Y1
Chao, JP; Cheng, L; Ju, RJ; Li, CQ; Li, XT; Liu, S; Peng, XM; Song, XL; Wang, T1
Cai, FY; Fu, M; Gong, XQ; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Tang, W; Yao, XM1
Hu, M; Li, F; Liu, W; Liu, Y; Liu, Z; Lu, L; Ou, R; Tong, Y; Wu, J; Zhang, G; Zheng, H; Zheng, L1
An, H; Cai, C; Gao, J; Geng, G; Jiang, J; Li, N; Liu, H; Mi, Y; Shen, D; Wu, X; Yang, S; Yu, X; Zheng, L1
Ba, Q; Chen, K; Chen, T; Li, J; Li, X; Liu, H; Liu, Y; Wang, H; Zhang, X; Zhou, Y1
Li, A; Lou, XE; Wang, Z; Zhang, JL; Zhou, HJ1
Azimian, S; Bair, WB; Cabello, CM; Lamore, SD; Lesson, JL; Qiao, S; Wondrak, GT1

Other Studies

9 other study(ies) available for artenimol and Metastase

ArticleYear
[Preliminary study of dihydroartemisin in inhibiting invasion and metastasis of hepatoma cells].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2020, Volume: 45, Issue:3

    Topics: Artemisinins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; ErbB Receptors; Humans; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Signal Transduction

2020
Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer.
    Journal of experimental & clinical cancer research : CR, 2017, 05-15, Volume: 36, Issue:1

    Topics: Animals; Antineoplastic Agents; Artemisinins; Biomarkers, Tumor; cdc42 GTP-Binding Protein; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Female; Gallbladder Neoplasms; Heterografts; Humans; Mice; Neoplasm Metastasis; Neoplasm Staging; Tumor Protein, Translationally-Controlled 1

2017
Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup1

    Topics: Ammonium Sulfate; Animals; Artemisinins; Biological Transport; Breast Neoplasms; Cell Movement; Daunorubicin; Humans; Lipid Bilayers; Liposomes; MCF-7 Cells; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Octreotide; Polyethylene Glycols; Wound Healing; Xenograft Model Antitumor Assays

2018
Development of R
    Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1

    Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Drug Liberation; Epirubicin; Humans; Lipid Bilayers; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Polyethylene Glycols; Xenograft Model Antitumor Assays

2019
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
    Oncotarget, 2016, May-24, Volume: 7, Issue:21

    Topics: A549 Cells; Animals; Antimalarials; Artemisinins; Artesunate; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; RNA Interference; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2016
Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis.
    Oncotarget, 2016, Dec-27, Volume: 7, Issue:52

    Topics: Animals; Antimalarials; Artemisinins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Female; Glucose Transporter Type 1; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B

2016
Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.
    EBioMedicine, 2016, Volume: 14

    Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Epithelial-Mesenchymal Transition; Female; Humans; Mice; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2016
Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro.
    Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Carcinoma, Lewis Lung; Cell Cycle; Cell Proliferation; Cell Survival; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Random Allocation; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2010
The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis.
    Investigational new drugs, 2012, Volume: 30, Issue:4

    Topics: Antimalarials; Antioxidants; Apoptosis; Artemisinins; Caspase 3; Cells, Cultured; Cytoprotection; DNA Damage; Drug Screening Assays, Antitumor; Enzyme Activation; Epidermis; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Iron Chelating Agents; Melanocytes; Melanoma; Mitochondria; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Up-Regulation

2012